Jazz Pharmaceuticals (JAZZ) grants 1,605 restricted stock units to director

Rhea-AI Filing Summary

ENRIGHT PATRICK G reported acquisition or exercise transactions in this Form 4 filing.

Jazz Pharmaceuticals director Patrick G. Enright received a grant of 1,605 restricted stock units, each representing a contingent right to one ordinary share upon vesting, under the 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Subject to continuous service and conditions, the units vest in full on July 23, 2027, bringing his reported holdings for this security to 22,984 shares.

Insider Trade Summary

Net Buyer: 1,605 shares

Net Buy 1 txn

Insider ENRIGHT PATRICK G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	1,605	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 22,984 shares (Direct)

Footnotes (1)

1. F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

Key Figures

RSUs Granted: 1,605 shares Holdings After Transaction: 22,984 shares Grant Price: $0.0000 per share +1 more

4 metrics

RSUs Granted 1,605 shares Restricted stock units granted to director Patrick G. Enright on August 5, 2026

Holdings After Transaction 22,984 shares Total reported holdings for this ordinary share line following the award

Grant Price $0.0000 per share RSU award recorded with no cash exercise or purchase price

Vesting Date July 23, 2027 Date on which the restricted stock units vest in full, subject to conditions

Key Terms

restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan

4 terms

restricted stock units financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one ordinary"

continuous service financial

"Subject to the Reporting Person's continuous service and certain additional"

Non-Employee Directors Stock Award Plan financial

"Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 05:37 PM Accepted by SEC EDGAR 08/07/2026 - 05:37 PM Learn about SEC filing dates

FAQ

What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Patrick G. Enright?

Jazz Pharmaceuticals reported that director Patrick G. Enright received a grant of 1,605 restricted stock units, each representing one ordinary share upon vesting. The award is part of the company’s non-employee director stock plan and was recorded at $0.00 per share.

How many Jazz Pharmaceuticals (JAZZ) restricted stock units were granted to Patrick G. Enright?

Director Patrick G. Enright was granted 1,605 restricted stock units by Jazz Pharmaceuticals. Each unit represents a contingent right to receive one ordinary share upon vesting, under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan for non-employee directors.

When do Patrick G. Enright’s Jazz Pharmaceuticals (JAZZ) restricted stock units vest?

The reported restricted stock units are scheduled to vest in full on July 23, 2027. Vesting is subject to Mr. Enright’s continuous service and certain additional conditions specified in the company’s non-employee director stock award plan governing these units.

What are Patrick G. Enright’s reported Jazz Pharmaceuticals (JAZZ) holdings after this award?

Following the grant, Mr. Enright’s reported holdings for this security total 22,984 shares. This figure comes from the Form 4’s post-transaction balance for the ordinary share line associated with the restricted stock unit award reported in the filing.

Under what plan were the Jazz Pharmaceuticals (JAZZ) restricted stock units granted to Patrick G. Enright?

The restricted stock units were granted under Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan. This plan provides stock-based compensation to non-employee directors, with each unit representing a right to receive one ordinary share upon vesting.

Do the reported Jazz Pharmaceuticals (JAZZ) units give Patrick G. Enright immediate shares?

No. Each restricted stock unit represents a contingent right to receive one ordinary share upon vesting. The units will vest in full on July 23, 2027, assuming continuous service and satisfaction of certain additional conditions described in the plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ENRIGHT PATRICK G

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/05/2026		A(1)		1,605	A	$0.0	22,984	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

	By: /s/Paz Dizon, as attorney in fact For: Patrick G. Enright	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)